In the present study, we demonstrate that the loss of CD109 reduces stemness and tumorigenicity in vitro and abrogates tumor initiation and the metastatic ability of vulvar SCC cells in vivo, indicating an oncogenic role for CD109 in vulvar SCC. Here, CD109 is linked to neoplasm.